STOK
$24.17-1.79%
Stoke Therapeutics Inc.Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%US Stock Market 0.003%Russell 3000 0.002%
STOK financial statements
The full income statement, balance sheet, and cash-flow statement for Stoke Therapeutics Inc. (STOK), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 52.6M2024-09 53.0M2024-12 54.1M2025-03 54.6M2025-06 54.8M2025-09 57.1M2025-12 59.2M2026-03 62.3M2026-06 64.5M+22.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 184M+404.5% | 36.6M+316.3% | 8.78M-29.2% | 12.4M | — | |
| 205M+48.6% | 138M+11.6% | 124M+5.8% | 117M+35.7% | 86.1M+62.3% | ||
| Research & development | 138M+54.7% | 89.1M+8.4% | 82.2M+5.6% | 77.8M+43.7% | 54.2M+68.2% | |
| Selling, general & administrative | 67.1M+37.5% | 48.8M+18.1% | 41.3M+6.2% | 38.9M+22.0% | 31.9M+53.0% | |
| General & administrative | — | 48.8M+18.1% | 41.3M+6.2% | 38.9M+22.0% | 31.9M+53.0% | |
| Operating income | -20.6M+79.7% | -101M+11.7% | -115M-10.0% | -104M-21.3% | -86.1M-62.3% | |
| Interest expense | 9.00K-65.4% | 26.0K-46.9% | 49.0K | — | — | |
| Interest & investment income | 13.8M+8.7% | 12.7M+27.2% | 9.96M | — | — | |
| Other non-operating income | -51.0K+79.4% | -247K-248.8% | 166K-0.6% | 167K+19.3% | 140K+38.6% | |
| Income tax | 0.00 | — | — | — | — | |
| Net income | -6.88M+92.3% | -89.0M+15.0% | -105M-3.6% | -101M-17.8% | -85.8M-64.2% | |
| -$0.12+92.7% | -$1.65+30.7% | -$2.38+8.5% | -$2.60-11.1% | -$2.34 | ||
| EPS (basic) | -$0.12+92.7% | -$1.65+30.7% | -$2.38+8.5% | -$2.60-11.1% | -$2.34 | |
| Weighted-avg shares (basic) | 59.2M+9.6% | 54.0M+22.8% | 44.0M+13.1% | 38.9M+5.9% | 36.7M | |
| Weighted-avg shares (diluted) | 59.2M+9.6% | 54.0M+22.8% | 44.0M+13.1% | 38.9M+5.9% | 36.7M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 306M+31.3% | 233M+8.1% | 215M-11.8% | 244M+6.5% | 229M-22.0% | ||
| Cash & equivalents | 84.2M-34.2% | 128M-33.1% | 191M+68.6% | 114M-21.6% | 145M-49.6% | |
| Accounts receivable | 5.94M+255.9% | 1.67M | — | — | — | |
| Prepaid expenses | 8.74M-21.4% | 11.1M-1.8% | 11.3M+3.5% | 10.9M+19.4% | 9.16M+42.3% | |
| Other current assets | 4.39M+91.1% | 2.30M-10.3% | 2.56M-13.3% | 2.96M+33.3% | 2.22M | |
| 418M+54.1% | 272M+18.9% | 228M-10.8% | 256M+7.2% | 239M-19.8% | ||
| Property, plant & equipment | 3.15M-19.5% | 3.91M-32.9% | 5.82M-12.8% | 6.67M+61.3% | 4.14M+54.7% | |
| Operating lease right-of-use | 3.10M-28.6% | 4.34M-34.3% | 6.61M+39.1% | 4.75M-3.8% | 4.94M+343.0% | |
| 57.9M+44.5% | 40.1M+30.0% | 30.8M-1.8% | 31.4M+83.2% | 17.1M+50.0% | ||
| Accounts payable | 4.94M+97.7% | 2.50M+47.4% | 1.70M+121.3% | 766K-67.9% | 2.38M+59.5% | |
| Deferred revenue | 11.9M-37.3% | 19.0M+24.1% | 15.3M+2.9% | 14.9M | — | |
| Current lease liability | 3.01M+29.5% | 2.32M+12.6% | 2.06M-12.6% | 2.36M+56.5% | 1.51M+41.4% | |
| Other current liabilities | 1.06M+40.8% | 753K-12.1% | 857K+68.4% | 509K-5.7% | 540K+17.6% | |
| 66.0M+55.1% | 42.5M-38.2% | 68.8M-3.4% | 71.2M+237.7% | 21.1M+78.0% | ||
| Deferred revenue (non-current) | 6.96M | — | 33.1M-10.3% | 36.9M | — | |
| Non-current lease liability | 1.14M-53.5% | 2.45M-48.6% | 4.77M+75.7% | 2.72M-23.1% | 3.53M+4315.0% | |
| Operating lease liability (total) | 4.15M-13.1% | 4.77M-30.2% | 6.83M+34.7% | 5.08M-27.2% | 6.97M+508.6% | |
| Other non-current liabilities | 1.14M-54.0% | 2.48M-49.3% | 4.88M+64.6% | 2.97M-24.8% | 3.95M | |
| Total non-current liabilities | 8.10M+227.0% | 2.48M-93.5% | 38.0M-4.7% | 39.8M+908.5% | 3.95M+835.8% | |
| 352M+53.9% | 229M+43.5% | 160M-13.7% | 185M-15.1% | 218M-23.9% | ||
| Common stock | 5.00K+0.0% | 5.00K+0.0% | 5.00K+25.0% | 4.00K+0.0% | 4.00K+0.0% | |
| Additional paid-in capital | 850M+18.0% | 720M+28.2% | 561M+16.2% | 483M+16.7% | 414M+4.5% | |
| Retained earnings | -498M-1.4% | -491M-22.1% | -402M-35.2% | -297M-51.5% | -196M-77.8% | |
| Accumulated other comprehensive income | 543K+459.6% | -151K-529.2% | -24.0K+98.0% | -1.18M-599.4% | -168K | |
| Total liabilities & equity | 418M+54.1% | 272M+18.9% | 228M-10.8% | 256M+7.2% | 239M-19.8% | |
| Common shares issued | 58.9M+9.0% | 54.0M+17.7% | 45.9M+16.4% | 39.4M+6.9% | 36.9M+0.9% | |
| Common shares outstanding | 58.9M+9.0% | 54.0M+17.7% | 45.9M+16.4% | 39.4M+6.9% | 36.9M+0.9% | |
| Shares outstanding (cover) | 59.2M+9.4% | 54.1M+16.8% | 46.3M+4.9% | 44.1M+18.2% | 37.4M+1.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 45.6M+152.5% | -86.9M-7.1% | -81.1M-154.4% | -31.9M+52.4% | -66.9M-58.5% | ||
| Depreciation & amortization | 1.77M-18.7% | 2.18M-11.8% | 2.47M+59.7% | 1.55M+58.7% | 974K+9.7% | |
| Share-based compensation | 32.2M+17.4% | 27.5M+8.8% | 25.3M+10.5% | 22.9M+38.9% | 16.4M+185.2% | |
| Change in receivables | 4.27M+8436.0% | 50.0K | — | — | — | |
| -187M-73.8% | -107M-201.4% | 106M+330.9% | -45.9M+40.0% | -76.4M-7178.7% | ||
| Capital expenditure | 670K+230.0% | 203K-87.4% | 1.62M-59.2% | 3.96M+230.2% | 1.20M+14.3% | |
| Free cash flow | 44.9M+151.6% | -87.1M-5.3% | -82.7M-130.8% | -35.8M+47.4% | -68.1M-57.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 97.4M-25.7% | 131M+147.3% | 53.0M+14.2% | 46.4M+3514.4% | 1.28M-98.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | — | — | 0.00-100.0% | 1.00K+150.0% | -2.00K | |
| Net change in cash | -43.8M+30.7% | -63.2M-181.2% | 77.9M+348.5% | -31.3M+77.9% | -142M-319.1% | |
| Income taxes paid | 573K | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.88B+214.8% | 596M+154.0% | 235M-35.5% | 364M-59.4% | 896M-60.5% | |
| P/S | 10.2×-37.6% | 16.3×-35.8% | 25.4× | — | — | |
| P/B | 5.3×+104.5% | 2.6×+91.8% | 1.4×-23.8% | 1.8×-56.7% | 4.1×-48.1% | |
| P/FCF | 41.8× | — | — | — | — | |
| FCF yield | 2.4% | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: STOK’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all STOK filings on SEC EDGAR → Not investment advice.